🇺🇸 FDA
Patent

US 11576924

Compounds for the prevention and treatment of diseases and the use thereof

granted A61KA61K31/7056A61K45/06

Quick answer

US patent 11576924 (Compounds for the prevention and treatment of diseases and the use thereof) held by Galectin Sciences, LLC expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Galectin Sciences, LLC
Grant date
Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/7056, A61K45/06, A61P, A61P1/16